Articles
-
1 week ago |
globalventuring.com | Yoana Cholteeva
Wonderstone Ventures will target global investments at seed and early stages. Japanese electronics producer Murata Manufacturing is launching a US-based corporate venture capital arm, Wonderstone Ventures, targeting startup business investments in the US. It plans to invest $50m over the next five years in next-generation communication, 6G, optics and semiconductors, bioelectronics, environment, robotics and space tech. It will invest globally in seed and early stage startups.
-
1 week ago |
globalventuring.com | Yoana Cholteeva
Steindl is joining a new venture capital form focused on European technology scale-ups. Lukas Steindl has left Uniqa Ventures, the CVC arm of Austria’s Uniqa Insurance Group. Steindl spent three years at Uniqa Ventures, where he rose through the ranks from an investment analyst to a manager with a focus on healthtech, insurtech and fintech.
-
1 week ago |
globalventuring.com | Yoana Cholteeva
The rebranded investment company welcomed the European Investment Fund as an anchor investor in its Growth Fund I. Axa Venture Partners, the former investment arm of French insurance company Axa, has announced its rebrand as Atlantic Vantage Point (AVP), becoming an independent private investment firm after the completion of its management buyout announced last year. Axa will remain an anchor investor in its €1.5bn ($1.7bn) growth fund, AVP Growth I.
-
2 weeks ago |
globalventuring.com | Yoana Cholteeva
The hire is part of its goal to strengthen its presence in the biotech sector and expand its international investment platform. Angelini Ventures, the investment arm of Italian industrial group Angelini Industries, has hired Regina Hodits as a managing director. Based in Germany, Hodits will lead Angelini Ventures’ international biotech investment strategy while supporting innovation in therapeutics and biotech AI.
-
2 weeks ago |
globalventuring.com | Yoana Cholteeva
The launch of the fund follows Sanofi’s investment in a $1bn insulin production facility in Beijing, China. French pharmaceutical and healthcare firm Sanofi has partnered with investment firm Cathay Capital to launch a $275m fund that will invest in clinical-stage drugs in China. The new fund, first reported by DealStreetAsia, was announced during a ceremony in Sanofi’s Shanghai office earlier this week.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 168
- Tweets
- 74
- DMs Open
- Yes
RT @PeopleMgt: In the closing keynote session at the CIPD #FestivalofWork, the comedian and writer talked about the importance of setting b…
What a true leader Larry the Cat is!
It’s has been a pleasure to serve you all for these last 12 years. If you’re ever asked if you have a cat, but don’t have the joy of one at home, know that you can answer yes; because I am yours and always will be x (Pic @PjrFoto) https://t.co/ssFRpWlumB
RT @AJMHLIMITED: This clearly highlights the growing importance that employees put on well-being in the workplace. Thanks to @cholteeva fo…
